Neoleukin Therapeutics
Why Robinhood?
You can watch NLTX and buy or sell other stocks, ETFs, and their options commission-free!About NLTX
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NLTX Key Statistics
Stock Snapshot
Neoleukin Therapeutics(NLTX) stock is priced at $30.09, giving the company a market capitalization of 469.88M. It carries a P/E multiple of -5.74.
On 2026-06-10, Neoleukin Therapeutics(NLTX) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Neoleukin Therapeutics(NLTX) stock has reached 0, versus its average volume of 138.64K.
The stock's 52-week range extends from a low of $14.65 to a high of $37.27.
The stock's 52-week range extends from a low of $14.65 to a high of $37.27.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.